T-BET and EOMES sustain mature human NK cell identity and antitumor function.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
03 07 2023
Historique:
received: 09 06 2022
accepted: 19 05 2023
medline: 4 7 2023
pubmed: 6 6 2023
entrez: 6 6 2023
Statut: epublish

Résumé

Since the T-box transcription factors (TFs) T-BET and EOMES are necessary for initiation of NK cell development, their ongoing requirement for mature NK cell homeostasis, function, and molecular programming remains unclear. To address this, T-BET and EOMES were deleted in unexpanded primary human NK cells using CRISPR/Cas9. Deleting these TFs compromised in vivo antitumor response of human NK cells. Mechanistically, T-BET and EOMES were required for normal NK cell proliferation and persistence in vivo. NK cells lacking T-BET and EOMES also exhibited defective responses to cytokine stimulation. Single-cell RNA-Seq revealed a specific T-box transcriptional program in human NK cells, which was rapidly lost following T-BET and EOMES deletion. Further, T-BET- and EOMES-deleted CD56bright NK cells acquired an innate lymphoid cell precursor-like (ILCP-like) profile with increased expression of the ILC-3-associated TFs RORC and AHR, revealing a role for T-box TFs in maintaining mature NK cell phenotypes and an unexpected role of suppressing alternative ILC lineages. Our study reveals the critical importance of sustained EOMES and T-BET expression to orchestrate mature NK cell function and identity.

Identifiants

pubmed: 37279078
pii: 162530
doi: 10.1172/JCI162530
pmc: PMC10313375
doi:
pii:

Substances chimiques

T-Box Domain Proteins 0
Transcription Factors 0
Cytokines 0
EOMES protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA205239
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA248235
Pays : United States
Organisme : NIGMS NIH HHS
ID : F31 GM146361
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007088
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007200
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM139799
Pays : United States
Organisme : NIAID NIH HHS
ID : F30 AI161318
Pays : United States

Références

Cancer Discov. 2020 Dec;10(12):1854-1871
pubmed: 32826231
J Leukoc Biol. 2002 Feb;71(2):173-83
pubmed: 11818437
Blood. 2020 Jul 16;136(3):288-298
pubmed: 32350509
Sci Immunol. 2021 Mar 12;6(57):
pubmed: 33712472
J Immunol. 2008 Dec 15;181(12):8700-10
pubmed: 19050290
Blood. 2008 Nov 15;112(10):4109-16
pubmed: 18784374
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Blood. 2023 Feb 23;141(8):846-855
pubmed: 36327161
J Exp Med. 2005 Oct 17;202(8):1075-85
pubmed: 16230475
J Biol Chem. 2008 Mar 28;283(13):8202-10
pubmed: 18230609
Eur J Immunol. 2018 May;48(5):738-750
pubmed: 29424438
Nat Commun. 2021 Sep 14;12(1):5446
pubmed: 34521844
Nat Immunol. 2016 Apr;17(4):451-60
pubmed: 26878113
Bioinformatics. 2019 Feb 1;35(3):421-432
pubmed: 30020410
J Exp Med. 2009 Jan 16;206(1):51-9
pubmed: 19139168
J Immunol. 2009 Aug 1;183(3):1695-704
pubmed: 19592655
Front Immunol. 2017 Nov 16;8:1569
pubmed: 29201028
Blood. 2022 Mar 17;139(11):1670-1683
pubmed: 34871371
EMBO J. 2014 Nov 18;33(22):2721-34
pubmed: 25319415
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Oncoimmunology. 2017 Feb 7;6(2):e1267892
pubmed: 28344878
Nat Rev Drug Discov. 2020 Mar;19(3):200-218
pubmed: 31907401
Cell Rep. 2020 Jun 2;31(9):107720
pubmed: 32492428
Immunity. 2018 Jun 19;48(6):1104-1117
pubmed: 29924976
Immunity. 2018 Nov 20;49(5):971-986.e5
pubmed: 30413361
J Immunol. 2005 May 15;174(10):6477-89
pubmed: 15879151
Front Immunol. 2014 May 14;5:217
pubmed: 24860576
Nat Immunol. 2015 Nov;16(11):1124-33
pubmed: 26414766
Blood Adv. 2020 Apr 14;4(7):1388-1406
pubmed: 32271902
Blood. 2008 Aug 1;112(3):461-9
pubmed: 18650461
Mol Cell Biol. 2014 Mar;34(6):1158-69
pubmed: 24421391
J Exp Med. 2015 Nov 16;212(12):2015-25
pubmed: 26503444
Clin Cancer Res. 2014 Apr 15;20(8):2044-50
pubmed: 24737791
BMC Bioinformatics. 2006 Mar 09;7:123
pubmed: 16526949
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Front Med (Lausanne). 2016 Jan 05;2:93
pubmed: 26779484
Genome Biol. 2001;2(12):REVIEWS3014
pubmed: 11790262
Nat Immunol. 2019 Aug;20(8):980-991
pubmed: 31209406
Immunity. 1998 Oct;9(4):555-63
pubmed: 9806641
Mol Cell Biol. 2007 Dec;27(24):8510-21
pubmed: 17923685
Semin Hematol. 2020 Oct;57(4):185-193
pubmed: 33256911
Blood. 2020 Nov 12;136(20):2308-2318
pubmed: 32614951
Leukemia. 2012 May;26(5):991-1000
pubmed: 22064350
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3394-402
pubmed: 27226296
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Front Immunol. 2016 Jun 20;7:241
pubmed: 27379101
Front Immunol. 2021 Sep 24;12:732511
pubmed: 34630413
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Immunol. 2021 Feb 1;206(3):465-470
pubmed: 33443057
J Exp Med. 2009 Oct 26;206(11):2469-81
pubmed: 19808259
Immunity. 2018 Sep 18;49(3):464-476.e4
pubmed: 30193847
Cell. 2020 Dec 23;183(7):1826-1847.e31
pubmed: 33296702
Blood. 2023 Feb 23;141(8):856-868
pubmed: 36416736
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5370-5
pubmed: 27114551
Sci Transl Med. 2022 Feb 23;14(633):eabm1375
pubmed: 35196021
Cell Rep. 2014 Jul 10;8(1):150-62
pubmed: 24953655
Front Immunol. 2020 May 22;11:1008
pubmed: 32528479
Immunity. 2004 Apr;20(4):477-94
pubmed: 15084276
Immunity. 2016 May 17;44(5):1140-50
pubmed: 27178467
Sci Transl Med. 2016 Sep 21;8(357):357ra123
pubmed: 27655849
Front Immunol. 2021 Jul 07;12:683680
pubmed: 34305917
Blood. 2001 May 15;97(10):3146-51
pubmed: 11342442
Immunology. 2020 Sep;161(1):28-38
pubmed: 32383173
FASEB J. 2007 Aug;21(10):2442-54
pubmed: 17360848
J Immunol. 1989 Nov 15;143(10):3183-91
pubmed: 2530273
Blood. 2005 Apr 15;105(8):3051-7
pubmed: 15632206
Nat Commun. 2019 Jul 24;10(1):3306
pubmed: 31341159
J Allergy Clin Immunol. 2016 Nov;138(5):1265-1276
pubmed: 27677386
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Sci Signal. 2016 Feb 16;9(415):ra19
pubmed: 26884601
J Immunol. 2016 Feb 15;196(4):1449-54
pubmed: 26792802
Immunity. 2012 Jan 27;36(1):55-67
pubmed: 22261438
J Exp Med. 2018 Sep 3;215(9):2379-2395
pubmed: 30061358
Cell Stem Cell. 2020 Aug 6;27(2):224-237.e6
pubmed: 32531207
Nat Immunol. 2008 May;9(5):503-10
pubmed: 18425107
Eur J Immunol. 2012 Aug;42(8):1916-23
pubmed: 22865043
J Allergy Clin Immunol. 2018 Jun;141(6):2265-2268.e1
pubmed: 29248494
J Exp Med. 2005 Feb 21;201(4):615-26
pubmed: 15728239
Nat Immunol. 2020 Oct;21(10):1205-1218
pubmed: 32839608
Blood. 2012 Jun 14;119(24):5758-68
pubmed: 22544698

Auteurs

Pamela Wong (P)

Department of Medicine, Division of Oncology.

Jennifer A Foltz (JA)

Department of Medicine, Division of Oncology.

Lily Chang (L)

Department of Medicine, Division of Oncology.

Carly C Neal (CC)

Department of Medicine, Division of Oncology.

Tony Yao (T)

Department of Medicine, Division of Oncology.

Celia C Cubitt (CC)

Department of Medicine, Division of Oncology.

Jennifer Tran (J)

Department of Medicine, Division of Oncology.

Samantha Kersting-Schadek (S)

Department of Medicine, Division of Oncology.

Sathvik Palakurty (S)

Department of Medicine, Division of Oncology.

Natalia Jaeger (N)

Department of Medicine, Division of Oncology.

David A Russler-Germain (DA)

Department of Medicine, Division of Oncology.

Nancy D Marin (ND)

Department of Medicine, Division of Oncology.

Margery Gang (M)

Department of Medicine, Division of Oncology.

Julia A Wagner (JA)

Department of Medicine, Division of Oncology.

Alice Y Zhou (AY)

Department of Medicine, Division of Oncology.

Miriam T Jacobs (MT)

Department of Medicine, Division of Oncology.

Mark Foster (M)

Department of Medicine, Division of Oncology.

Timothy Schappe (T)

Department of Medicine, Division of Oncology.

Lynne Marsala (L)

Department of Medicine, Division of Oncology.

Ethan McClain (E)

Department of Medicine, Division of Oncology.

Patrick Pence (P)

Department of Medicine, Division of Oncology.

Michelle Becker-Hapak (M)

Department of Medicine, Division of Oncology.

Bryan Fisk (B)

Department of Medicine, Division of Oncology.

Allegra A Petti (AA)

Department of Neurological Surgery, and.

Obi L Griffith (OL)

Department of Medicine, Division of Oncology.

Malachi Griffith (M)

Department of Medicine, Division of Oncology.

Melissa M Berrien-Elliott (MM)

Department of Medicine, Division of Oncology.

Todd A Fehniger (TA)

Department of Medicine, Division of Oncology.
Siteman Cancer Center, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH